CSPC Pharmaceutical Group Limited
(Incorporated in Hong Kong with limited liability)

Announcements & Notices       

2021-December-29	VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE PRMT5 INHIBITOR "SYHX2001" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2021-December-29	SUPPLEMENTAL ANNOUNCEMENT RELATING TO THE RENEWED LEASE AGREEMENTS (in PDF)
2021-December-22	CONNECTED TRANSACTIONS - RENEWAL OF LEASE AGREEMENTS (in PDF)
2021-December-22	CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF MASTER PURCHASE AGREEMENT (in PDF)
2021-December-14	VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE 1/2 CLINICAL TRIAL OF JMT601 IN THE U.S. (in PDF)
2021-December-3	VOLUNTARY ANNOUNCEMENT - INCLUSION OF ANFULIKE IN THE NATIONAL REIMBURSEMENT DRUG LIST (in PDF)
2021-November-22	CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF MASTER SALES AGREEMENT (in PDF)
2021-November-22	VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH KEYMED BIOSCIENCE (CHENGDU) CO., LTD. FOR CM326 (in PDF)
2021-November-18	QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2021 (in PDF)
2021-November-8	DATE OF BOARD MEETING (in PDF)
2021-October-21	INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THIRD QUARTER OF 2021 (in PDF)
2021-October-21	REVISION OF ANNUAL CAP FOR CONTINUING CONNECTED TRANSACTIONS (in PDF)
2021-October-15	VOLUNTARY ANNOUNCEMENT - "APIXABAN TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2021-September-30	REVISION OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS (in PDF)
2021-September-23	VOLUNTARY ANNOUNCEMENT - STRATEGIC ALLIANCE AGREEMENT WITH KEYMED BIOSCIENCE (CHENGDU) CO., LTD (in PDF)
2021-September-2	VOLUNTARY ANNOUNCEMENT - NBL-015 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
2021-September-1	VOLUNTARY ANNOUNCEMENT - "OSELTAMIVIR PHOSPHATE CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2021-August-26	2021 INTERIM DIVIDEND (in PDF)
2021-August-26	2021 INTERIM RESULTS ANNOUNCEMENT (in PDF)
2021-August-23	VOLUNTARY ANNOUNCEMENT - EXCLUSIVE LICENSE AGREEMENT WITH JIANGSU ALPHAMAB FOR THE DEVELOPMENT AND COMMERCIALIZATION OF KN026 IN CHINA (in PDF)
2021-August-19	INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE HALF YEAR ENDED 30 JUNE 2021 (in PDF)
2021-August-17	VOLUNTARY ANNOUNCEMENT - STRATEGIC PARTNERSHIP AND LICENSE AGREEMENT WITH FLAME BIOSCIENCES (in PDF)
2021-August-16	DATE OF BOARD MEETING (in PDF)
2021-August-9	VOLUNTARY ANNOUNCEMENT - "AFATINIB DIMALEATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2021-July-16	VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE "SYSA1801" OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (in PDF)
2021-June-25	VOLUNTARY ANNOUNCEMENT - "TOFACITINIB CITRATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2021-June-16	VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE "SYSA1801" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
2021-June-9	VOLUNTARY ANNOUNCEMENT - ANTI-TUMOR NANODRUG "SIROLIMUS FOR INJECTION (ALBUMIN-BOUND)" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2021-June-8	VOLUNTARY ANNOUNCEMENT - "PREGABALIN CAPSULES" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2021-May-31	VOLUNTARY ANNOUNCEMENT - "LACOSAMIDE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2021-May-25	VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE CDK9 INHIBITOR "SYHX1903" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
2021-May-25	VOLUNTARY ANNOUNCEMENT - "LINAGLIPTIN TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2021-May-25	VOLUNTARY ANNOUNCEMENT - NBL-015 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (in PDF)
2021-May-24	QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2021 (in PDF)
2021-May-20	VOLUNTARY ANNOUNCEMENT - INNOVATIVE DRUG "SYHA1811 TABLETS" OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
2021-May-18	POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 18 MAY 2021 (in PDF)
2021-May-11	DATE OF BOARD MEETING (in PDF)
2021-May-11	VOLUNTARY ANNOUNCEMENT - "SITAGLIPTIN PHOSPHATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2021-May-11	VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION" (in PDF)
2021-May-11	VOLUNTARY ANNOUNCEMENT - "SORAFENIB TOSYLATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2021-May-11	VOLUNTARY ANNOUNCEMENT - "ALOGLIPTIN BENZOATE TABLETS" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2021-May-7	VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL FIRST-IN-CLASS PRODUCT SYSA1801 GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA (in PDF)
2021-April-30	CONNECTED TRANSACTION - DISPOSAL OF 49.5% EQUITY INTEREST IN JOINT VENTURE COMPANY /CONTINUING CONNECTED TRANSACTIONS - MASTER PURCHASE AGREEMENT (in PDF)
2021-April-26	INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2021 (in PDF)
2021-April-23	VOLUNTARY ANNOUNCEMENT - NBL-012 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
2021-April-19	VOLUNTARY ANNOUNCEMENT - APPLICATION FOR MARKETING APPROVAL OF "DUVELISIB CAPSULES" ACCEPTED BY NMPA (in PDF)
2021-April-14	NOTICE OF ANNUAL GENERAL MEETING (in PDF)
2021-April-9	INVESTIGATIONAL NEW DRUG NBL-015 GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA (in PDF)
2021-April-1	VOLUNTARY ANNOUNCEMENT - "AMPHOTERICIN B CHOLESTERYL SULFATE COMPLEX FOR INJECTION" OBTAINS DRUG REGISTRATION APPROVAL (in PDF)
2021-March-30	VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF "DOCETAXEL FOR INJECTION (ALBUMIN-BOUND)" (in PDF)
2021-March-29	VOLUNTARY ANNOUNCEMENT - JMT601 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (in PDF)
2021-March-25	VOLUNTARY ANNOUNCEMENT - JMT601 OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (in PDF)
2021-March-16	VOLUNTARY ANNOUNCEMENT - DUAL INHIBITOR JAK-SyK "SYHX1901" OBTAINS CLINICAL TRIAL APPROVAL (in PDF)
2021-March-15	ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020 (in PDF)
2021-March-10	VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT (in PDF)
2021-March-9	VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT (in PDF)
2021-March-9	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2021-March-5	APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS (in PDF)
2021-March-5	POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 5 MARCH 2021 (in PDF)
2021-March-4	INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 December 2020 (in PDF)
2021-March-3	DATE OF BOARD MEETING (in PDF)
2021-February-7	NOTICE OF 2021 FIRST EXTRAORDINARY GENERAL MEETING (in PDF)
2021-February-1	PROPOSED ISSUE OF RMB SHARES UNDER SPECIFIC MANDATE PROPOSED AMENDMENTS TO ARTICLES OF ASSOCIATION (in PDF)
2021-January-27	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2021-January-27	APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE OF BOARD COMMITTEE S (in PDF)
2021-January-8	VOLUNTARY ANNOUNCEMENT - NBL-012 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (in PDF)
2024	2024 Announcements & Notices
2023	2023 Announcements & Notices
2022	2022 Announcements & Notices
2020	2020 Announcements & Notices
2019	2019 Announcements & Notices
2018	2018 Announcements & Notices
2017	2017 Announcements & Notices
2016	2016 Announcements & Notices
2015	2015 Announcements & Notices
2014	2014 Announcements & Notices
2013	2013 Announcements & Notices
2012	2012 Announcements & Notices
2011	2011 Announcements & Notices
2010	2010 Announcements & Notices
2009	2009 Announcements & Notices
2008	2008 Announcements & Notices
2007	2007 Announcements & Notices
2006	2006 Announcements & Notices